PTC THERAPEUTICS, INC. — Director's Dealing 2020

Dec 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2020-12-08

Reporting Person: Okey Stephanie (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-08	Common Stock	S	687	$62.524	Disposed	963	Direct

Footnotes

F1: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $62.49 to $62.53 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.